DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.
Although osteosarcoma (OS) is a rare cancer, it is the most common primary malignant bone tumor in children and adolescents. BRCAness is a phenotypical trait in tumors with a defect in homologous recombination repair, resembling tumors with inactivation of BRCA1/2, rendering these tumors sensitive t...
Main Authors: | Maxim Barenboim, Michal Kovac, Baptiste Ameline, David T W Jones, Olaf Witt, Stefan Bielack, Stefan Burdach, Daniel Baumhoer, Michaela Nathrath |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-11-01
|
Series: | PLoS Computational Biology |
Online Access: | https://doi.org/10.1371/journal.pcbi.1009562 |
Similar Items
-
DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma
by: Maxim Barenboim, et al.
Published: (2021-11-01) -
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?
by: Baptiste Ameline, et al.
Published: (2021-03-01) -
NTRK fusions in osteosarcoma are rare and non‐functional events
by: Baptiste Ameline, et al.
Published: (2020-04-01) -
Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group
by: Vanessa L. Mettmann, et al.
Published: (2023-09-01) -
The BRCAness Landscape of Cancer
by: Maoni Guo, et al.
Published: (2022-12-01)